N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide;N-(1-amino-4-methyl-1,2-dioxohexan-3-yl)-3-methyl-5-phenyl-1,2-oxazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-3-[4-(1,3-oxazol-2-yl)-2-pyridinyl]imidazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide;N-(1-oxo-3-phenylpropan-2-yl)-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide
C117H106N26O16 — CID 159317213
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide;N-(1-amino-4-methyl-1,2-dioxohexan-3-yl)-3-methyl-5-phenyl-1,2-oxazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-3-[4-(1,3-oxazol-2-yl)-2-pyridinyl]imidazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide;N-(1-oxo-3-phenylpropan-2-yl)-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide
N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide;N-(1-amino-4-methyl-1,2-dioxohexan-3-yl)-3-methyl-5-phenyl-1,2-oxazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-3-[4-(1,3-oxazol-2-yl)-2-pyridinyl]imidazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide;N-(1-oxo-3-phenylpropan-2-yl)-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide (PubChem CID 159317213) has the molecular formula C117H106N26O16 and a molecular weight of 2132.30 g/mol. Its IUPAC name is N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide;N-(1-amino-4-methyl-1,2-dioxohexan-3-yl)-3-methyl-5-phenyl-1,2-oxazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-3-[4-(1,3-oxazol-2-yl)-2-pyridinyl]imidazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide;N-(1-oxo-3-phenylpropan-2-yl)-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide.
Molecular Properties
| Compound Name | N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide;N-(1-amino-4-methyl-1,2-dioxohexan-3-yl)-3-methyl-5-phenyl-1,2-oxazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-3-[4-(1,3-oxazol-2-yl)-2-pyridinyl]imidazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide;N-(1-oxo-3-phenylpropan-2-yl)-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide |
|---|---|
| PubChem CID | 159317213 |
| Molecular Formula | C117H106N26O16 |
| Molecular Weight | 2132.30 g/mol |
| Exact Mass | 2130.83 |
| IUPAC Name | N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide;N-(1-amino-4-methyl-1,2-dioxohexan-3-yl)-3-methyl-5-phenyl-1,2-oxazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-3-[4-(1,3-oxazol-2-yl)-2-pyridinyl]imidazole-4-carboxamide;N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide;N-(1-oxo-3-phenylpropan-2-yl)-3-(5-phenylpyrimidin-2-yl)imidazole-4-carboxamide |
| SMILES | CCC(C)C(NC(=O)c1c(C)noc1-c1ccccc1)C(=O)C(N)=O.NC(=O)C(=O)C(Cc1ccccc1)NC(=O)c1cncn1-c1ncc(-c2ccccc2)cn1.O=C(NC1CC1)C(=O)C(Cc1ccccc1)NC(=O)c1cncn1-c1cc(-c2ncco2)ccn1.O=C(NC1CC1)C(=O)C(Cc1ccccc1)NC(=O)c1cncn1-c1ncc(-c2ccccc2)cn1.O=CC(Cc1ccccc1)NC(=O)c1cncn1-c1ncc(-c2ccccc2)cn1 |
| InChI | InChI=1S/C27H24N6O3.C25H22N6O4.C24H20N6O3.C23H19N5O2.C18H21N3O4/c34-24(26(36)31-21-11-12-21)22(13-18-7-3-1-4-8-18)32-25(35)23-16-28-17-33(23)27-29-14-20(15-30-27)19-9-5-2-6-10-19;32-22(24(34)29-18-6-7-18)19(12-16-4-2-1-3-5-16)30-23(33)20-14-26-15-31(20)21-13-17(8-9-27-21)25-28-10-11-35-25;25-22(32)21(31)19(11-16-7-3-1-4-8-16)29-23(33)20-14-26-15-30(20)24-27-12-18(13-28-24)17-9-5-2-6-10-17;29-15-20(11-17-7-3-1-4-8-17)27-22(30)21-14-24-16-28(21)23-25-12-19(13-26-23)18-9-5-2-6-10-18;1-4-10(2)14(15(22)17(19)23)20-18(24)13-11(3)21-25-16(13)12-8-6-5-7-9-12/h1-10,14-17,21-22H,11-13H2,(H,31,36)(H,32,35);1-5,8-11,13-15,18-19H,6-7,12H2,(H,29,34)(H,30,33);1-10,12-15,19H,11H2,(H2,25,32)(H,29,33);1-10,12-16,20H,11H2,(H,27,30);5-10,14H,4H2,1-3H3,(H2,19,23)(H,20,24) |
| InChIKey | LDHFJWPYNYFGFM-UHFFFAOYSA-N |
| XLogP | 11.07 |
| TPSA | 588.80 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 40 |
| Heavy Atoms | 159 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2132.30 |
| LogP ≤ 5 | 11.07 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 33 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159317213 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.